SRR934895
—
Clinical attributes
From the source cohort, normalized into canonical keys plus the project's native columns.
- cancer_type
- —
- cancer_type_detailed
- —
- subtype
- —
- sex
- Female
GSVA pathway preview (0 Hallmark scores)
Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.
Patient twins — nearest pathway neighbors
10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.
9 twins match this tumor's tissue · 1 come from a different tissue of origin
| # | Sample | Cancer type | Subtype | cos similarity |
|---|---|---|---|---|
| 1 | SRR934942 | — | — | 0.974 |
| 2 | SRR934925 | — | — | 0.958 |
| 3 | SRR934907 | — | — | 0.952 |
| 4 | SRR934802 | — | — | 0.950 |
| 5 | SRR934936 | — | — | 0.940 |
| 6 | SRR934875 | — | — | 0.938 |
| 7 | SRR934871 | — | — | 0.936 |
| 8 | 42B7A295-5E3D-44DA-B93F-40E64A551364 | — | — | 0.936 |
| 9 | BS_0WQJP6ZG | Supratentorial Ependymoma | — | 0.935 |
| 10 | SRR934825 | — | — | 0.934 |
Per-pathway drug coverage
For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.
0 of 39 elevated pathways have at least one drug that meaningfully reverses them.
| Pathway (elevated) | tumor score | Best drug | reversal magnitude |
|---|---|---|---|
| PROTEIN_SECRETION | 0.518 | Remibrutinib | — uncovered |
| TGF_BETA_SIGNALING | 0.494 | Inavolisib | — uncovered |
| G2M_CHECKPOINT | 0.491 | Inavolisib | — uncovered |
| IL6_JAK_STAT3_SIGNALING | 0.466 | Inavolisib | — uncovered |
| INTERFERON_GAMMA_RESPONSE | 0.440 | Idelalisib | — uncovered |
| INTERFERON_ALPHA_RESPONSE | 0.437 | Inavolisib | — uncovered |
| MITOTIC_SPINDLE | 0.429 | Inavolisib | — uncovered |
| E2F_TARGETS | 0.407 | Inavolisib | — uncovered |
| ALLOGRAFT_REJECTION | 0.388 | Idelalisib | — uncovered |
| ANDROGEN_RESPONSE | 0.378 | Inavolisib | — uncovered |
| MYC_TARGETS_V1 | 0.377 | Inavolisib | — uncovered |
| UNFOLDED_PROTEIN_RESPONSE | 0.371 | Idelalisib | — uncovered |
| EPITHELIAL_MESENCHYMAL_TRANSITION | 0.349 | Inavolisib | — uncovered |
| COMPLEMENT | 0.348 | Inavolisib | — uncovered |
| INFLAMMATORY_RESPONSE | 0.347 | Idelalisib | — uncovered |
| MTORC1_SIGNALING | 0.340 | Inavolisib | — uncovered |
| PI3K_AKT_MTOR_SIGNALING | 0.311 | Inavolisib | — uncovered |
| TNFA_SIGNALING_VIA_NFKB | 0.300 | Inavolisib | — uncovered |
| APOPTOSIS | 0.287 | Idelalisib | — uncovered |
| REACTIVE_OXYGEN_SPECIES_PATHWAY | 0.285 | Inavolisib | — uncovered |